Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 5613

1.

Intra-individual changes in Stroop-related activations linked to cigarette abstinence in adolescent tobacco smokers: Preliminary findings.

Yip SW, Balodis IM, Carroll KM, Krishnan-Sarin S, Potenza MN.

Drug Alcohol Depend. 2016 Aug 21. pii: S0376-8716(16)30259-9. doi: 10.1016/j.drugalcdep.2016.08.019. [Epub ahead of print]

PMID:
27567966
2.

Smoking cessation for people with chronic obstructive pulmonary disease.

van Eerd EA, van der Meer RM, van Schayck OC, Kotz D.

Cochrane Database Syst Rev. 2016 Aug 20;8:CD010744. [Epub ahead of print] Review.

PMID:
27545342
3.

A Randomized Trial of Contingency Management for Smoking Cessation During Intensive Outpatient Alcohol Treatment.

Cooney JL, Cooper S, Grant C, Sevarino K, Krishnan-Sarin S, Gutierrez IA, Cooney NL.

J Subst Abuse Treat. 2016 Jul 15. pii: S0740-5472(16)30038-1. doi: 10.1016/j.jsat.2016.07.002. [Epub ahead of print]

PMID:
27542442
4.

An individually-tailored smoking cessation intervention for rural Veterans: a pilot randomized trial.

Vander Weg MW, Cozad AJ, Howren MB, Cretzmeyer M, Scherubel M, Turvey C, Grant KM, Abrams TE, Katz DA.

BMC Public Health. 2016 Aug 17;16(1):811. doi: 10.1186/s12889-016-3493-z.

5.

Predictors of retention in a randomised trial of smoking cessation in low-socioeconomic status Australian smokers.

Courtney RJ, Clare P, Boland V, Martire KA, Bonevski B, Hall W, Siahpush M, Borland R, Doran CM, West R, Farrell M, Mattick RP.

Addict Behav. 2016 Aug 2;64:13-20. doi: 10.1016/j.addbeh.2016.07.019. [Epub ahead of print]

PMID:
27533077
6.

Drugs for Smoking Cessation.

CADTH Report / Project in Briefs [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011-.
2016 May.

7.

Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion and 4'-OH-bupropion in vitro.

Sager JE, Price LS, Isoherranen N.

Drug Metab Dispos. 2016 Aug 5. pii: dmd.116.072363. [Epub ahead of print]

PMID:
27495292
8.
9.

Cannabinoid Receptor 1 (CNR1) Gene Variant Moderates Neural Index of Cognitive Disruption during Nicotine Withdrawal.

Evans DE, Sutton SK, Jentink KG, Lin HY, Park JY, Drobes DJ.

Genes Brain Behav. 2016 Jul 25. doi: 10.1111/gbb.12311. [Epub ahead of print]

PMID:
27453054
10.

Integrating tobacco treatment into cancer care: Study protocol for a randomized controlled comparative effectiveness trial.

Park ER, Ostroff JS, Perez GK, Hyland KA, Rigotti NA, Borderud S, Regan S, Muzikansky A, Friedman ER, Levy DE, Holland S, Eusebio J, Peterson L, Rabin J, Miller-Sobel J, Gonzalez I, Malloy L, O'Brien M, de León-Sanchez S, Whitlock CW.

Contemp Clin Trials. 2016 Jul 19;50:54-65. doi: 10.1016/j.cct.2016.07.016. [Epub ahead of print]

PMID:
27444428
11.

Long-term follow-up of psilocybin-facilitated smoking cessation.

Johnson MW, Garcia-Romeu A, Griffiths RR.

Am J Drug Alcohol Abuse. 2016 Jul 21:1-6. [Epub ahead of print]

PMID:
27441452
12.

Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews.

Karmali KN, Lloyd-Jones DM, Berendsen MA, Goff DC Jr, Sanghavi DM, Brown NC, Korenovska L, Huffman MD.

JAMA Cardiol. 2016 Jun 1;1(3):341-9. doi: 10.1001/jamacardio.2016.0218.

PMID:
27438118
13.

Tobacco Use Cessation and Prevention - A Review.

Shaik SS, Doshi D, Bandari SR, Madupu PR, Kulkarni S.

J Clin Diagn Res. 2016 May;10(5):ZE13-7. doi: 10.7860/JCDR/2016/19321.7803. Epub 2016 May 1. Review.

14.

Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.

Do TC, Boettiger D, Law M, Pujari S, Zhang F, Chaiwarith R, Kiertiburanakul S, Lee MP, Ditangco R, Wong WW, Nguyen KV, Merati TP, Pham TT, Kamarulzaman A, Oka S, Yunihastuti E, Kumarasamy N, Kantipong P, Choi JY, Ng OT, Durier N, Ruxrungtham K.

HIV Med. 2016 Aug;17(7):542-9. doi: 10.1111/hiv.12358.

PMID:
27430354
15.

Carotid surgery today: an update after 14,000 carotid endarterectomy procedures.

Radak D, Ilijevski N, Djukić N.

Vojnosanit Pregl. 2016 May;73(5):472-9. Review. No abstract available.

PMID:
27430113
16.

New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

Beard E, Shahab L, Cummings DM, Michie S, West R.

CNS Drugs. 2016 Jul 15. [Epub ahead of print] Review.

PMID:
27421270
17.

Smoking cessation interventions within the context of Low-Dose Computed Tomography lung cancer screening: A systematic review.

Piñeiro B, Simmons VN, Palmer AM, Correa JB, Brandon TH.

Lung Cancer. 2016 Aug;98:91-8. doi: 10.1016/j.lungcan.2016.05.028. Epub 2016 Jun 1. Review.

PMID:
27393513
18.

A smoking cessation program for current and recent ex-smokers following diagnosis of a potentially curable cancer.

Ong J, Plueckhahn I, Cruickshank D, Churilov L, Mileshkin L.

Intern Med J. 2016 Jul 8. doi: 10.1111/imj.13172. [Epub ahead of print]

PMID:
27389637
19.

Management of Inflammatory Bowel Disease in the Elderly.

John ES, Katz K, Saxena M, Chokhavatia S, Katz S.

Curr Treat Options Gastroenterol. 2016 Sep;14(3):285-304. doi: 10.1007/s11938-016-0099-6. Review.

PMID:
27387455
20.

Prioritisation of treatments for lower extremity peripheral artery disease in low- and middle-income countries.

Fowkes FG, Forster R, Levin CE, Naidoo NG, Roy A, Shu C, Spertus J, Fang K, Bechara-Zamudio L, Catalano M, Visona A, Nikol S, Fletcher JP, Jaff MR, Hiatt WR, Norgren L; (TASC) on behalf of the Inter-Society Consensus for the Management of Peripheral Arterial Disease.

Int Angiol. 2016 Jul 7. [Epub ahead of print]

PMID:
27386953
Items per page

Supplemental Content

Loading ...
Write to the Help Desk